Clinical Trials Imaging Market Projected to Reach USD 981.53 Million to 2020, with 6.25% CAGR

Global clinical trials imaging market is expected to USD 981.53 million by 2020 from USD 724.87 million in 2015, at a CAGR of 6.25% between 2015 and 2020. By product, the market includes services & software. Clinical Trials Imaging Market by Modality, End User(Pharmaceutical Companies, CROs Medical device Manufacturers) and Products.

A combination of bottom-up and top-down approaches was used to calculate the market sizes and growth rates of the global clinical trials imaging market and its subsegments. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All possible parameters that affect the markets covered in Clinical Trials Imaging Market research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. Primary interviews with key opinion leaders were also used to determine the percentage shares of each subsegment and the relative differences in growth rates. The report provides qualitative insights about growth rates, and Clinical Trials Imaging Market drivers for all subsegments. It maps market sizes and growth rates for each subsegment and identifies segments poised for rapid growth in each geographic segment. The report also includes company profiles of market leaders

Browse 73 market data table & 76 figure spread through 142 page and in-depth TOC on " Clinical Trials Imaging Market" .

The geographic segments included in this report are North America, Europe, Asia, and Rest of the World (RoW). North America is expected to account for the largest share in the global clinical trials imaging market in 2015. Asia is expected to register the fastest growth. The growth of this market is mainly driven by growth in pharmaceutical & biotechnology industries, increase in R&D funding and increasing number of CROs. Major Players in this market include BioClinica, Inc. (U.S.), Biomedical Systems (U.S.), Cardiovascular Imaging Technologies (U.S.), ICON Public Limited Company (Ireland), Intrinsic Imaging, LLC (U.S.), IXICO, PLC (U.K.), PAREXEL International Corporation (U.S.), Radiant Sage, LLC (U.S.), VirtualScopic, Inc. (U.S.), and WorldCare Clinical, LLC (U.S.).

For more inquiry on this report at .

The services product segment is further classified into operational imaging services, systems & technology, reader services & design consulting. Based on modality, the market is segmented into CT, MRI, ultrasound, PET, X-rays, ECHO ad other modalities. The CT segment will hold the largest share of the clinical trials imaging market in 2015. Priced at $4650 for a single user PDF, a discount on “Clinical Trials Imaging Market by Modality (CT, MRI, PET, Ultrasound, Echocardiography, X-rays), End User (Pharmaceutical Companies, CROs Medical device Manufacturers), Product (Services, software), and Region - Global Forecast to 2020research report can be requested at .

About Us:

(Contact us @ / + 1 888 391 5441) is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.